Vasculitis and panniculitis associated with vemurafenib

Journal of the American Academy of Dermatology

Volumn 67, Issue 6, 2012, Pages

  Novoa, Roberto A ^a   Honda, Kord ^a   Koon, Henry B ^a   Gerstenblith, Meg R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOVECTIN; ALPHA2B INTERFERON; ANTINEOPLASTIC AGENT; CARBOPLATIN; DACARBAZINE; INTERLEUKIN 2; IPILIMUMAB; PACLITAXEL; UNCLASSIFIED DRUG; VEMURAFENIB;

ADULT; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; MEDICAL HISTORY; MELANOMA; PANNICULITIS; PRIORITY JOURNAL; VASCULITIS;

EID: 84869098832     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.05.019     Document Type: Article

References (5)

1. P.B. Chapman, A. Hauschild, C. Robert, J.B. Haanen, P. Ascierto, and J. Larkin Improved survival with vemurafenib in melanoma with BRAF V600E mutation N Engl J Med 364 2011 2507 2516
2. Justice RL. Center for Drug Evaluation and Research. Application number: 202429Orig1s000. Summary review. Available from: URL: http://www.accessdata.fda. gov/drugsatfda-docs/label/2011/202429Orig1s000SumR.pdf. Accessed October 31, 2011.
3. P.I. Poulikakos, C. Zhang, G. Bollag, K.M. Shokat, and N. Rosen RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF Nature 464 2010 427 430
4. K. Aomatsu, T. Kato, H. Fujita, F. Hato, N. Oshitani, and N. Kamata Toll-like receptor agonists stimulate human neutrophil migration via activation of mitogen-activated protein kinases Immunology 123 2008 171 180
5. L. Zimmer, E. Livingstone, U. Hillen, S. Domkes, A. Becker, and D. Schadendorf Panniculitis with arthralgia in patients with melanoma treated with selective BRAF inhibitors and its management Arch Dermatol 148 2012 357 361